摘要
小胶质细胞和星形胶质细胞在神经发展及维持健康大脑突触连接和体内平衡的意义已经确立。小胶质细胞是大脑损伤时引起免疫反应的动态免疫细胞,也参与组织修复和再生,而星形胶质细胞通过产生促炎细胞因子产生局部炎症通过抗炎细胞因子和神经营养因子的生产解决神经损伤,。最近的努力致力于阐明在正常和病理状态下调节神经胶质细胞的表观遗传机制。表观遗传监管机制的一个重要的分子是小分子核糖核苷酸,它是调节转录后基因表达的小非编码RNA分子,。某些特异表达有助于慢性小胶质脑部炎症,从而促进神经系统疾病研究进展如阿尔茨海默氏症、创伤性损伤,肌萎缩性脊髓侧索硬化症和中风。此外,缺血和脊椎损伤后,许多小分子核糖核苷酸在星形胶质细胞差异表达。尽管在神经炎症的小分子核糖核苷酸知识体系中,很少是关于小分子核糖核苷酸为基础疗法有效的配送路线和药代动力学数据。综述总结了小分子核糖核苷酸在小胶质细胞和星形胶质细胞以特定疾病的方式促进或抑制炎症反应的研究。此外,针对以小分子核糖核苷酸传送作为治疗神经炎症治疗策略进行了探讨。
关键词: 神经炎症、小胶质细胞、星形胶质细胞、小分子核糖核酸
Current Medicinal Chemistry
Title:MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies
Volume: 23 Issue: 30
Author(s): Aparna Karthikeyan, Radhika Patnala, Shweta P. Jadhav, Ling Eng-Ang, S. Thameem Dheen
Affiliation:
关键词: 神经炎症、小胶质细胞、星形胶质细胞、小分子核糖核酸
摘要: The significance of microglia and astrocytes in neural development, in maintaining synaptic connections and homeostasis in the healthy brain is well established. Microglia are dynamic immune cells of the brain that elicit an immune response during brain damage and also participate in tissue repair and regeneration, while astrocytes contribute to the local inflammatory response by producing proinflammatory cytokines and resolving neuronal damage through production of anti-inflammatory cytokines and neurotrophic factors. Recent efforts have focused on elucidating the epigenetic mechanisms which regulate glial cell behavior in normal and pathologic states. An important class of epigenetic regulators is microRNAs (miRNAs) which are small non-coding RNA molecules that regulate gene expression posttranscriptionally. Certain dysregulated miRNAs contribute to chronic microglial inflammation in the brain, thereby leading to progression of neurological diseases like Alzheimer’s disease, traumatic injury, amyotrophic lateral sclerosis and stroke. Further, several miRNAs are differentially expressed in astrocytes after ischemia and spinal cord injury. Despite knowledge about miRNAs in neuroinflammation, little is known about effective delivery routes and pharmacokinetic data for miRNA based therapeutics. This review summarizes the current research on the role of miRNAs in promoting and inhibiting inflammatory response of microglia and astrocytes in a disease-specific manner. In addition, miRNA delivery as a therapeutic strategy to treat neuroinflammation is discussed.
Export Options
About this article
Cite this article as:
Aparna Karthikeyan, Radhika Patnala, Shweta P. Jadhav, Ling Eng-Ang, S. Thameem Dheen , MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies, Current Medicinal Chemistry 2016; 23 (30) . https://dx.doi.org/10.2174/0929867323666160814001040
DOI https://dx.doi.org/10.2174/0929867323666160814001040 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effect of Sex and Gender on Diabetic Complications
Current Diabetes Reviews Drug Therapy in Brugada Syndrome
Current Drug Targets - Cardiovascular & Hematological Disorders Micronutrient Biofortification in Rice through New Breeding Techniques (NBTs): Bangladesh Perspective
Current Nutraceuticals Extensive Coronary Calcification: A Clinically Unrecognised Condition
Current Vascular Pharmacology Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Cocaine and Acute Vascular Diseases
Current Drug Abuse Reviews Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
Current Cardiology Reviews Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
Current HIV Research The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimers Disease
Current Genomics Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease
Current Pharmaceutical Design Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine The Development of New Concepts for Assessing Reproductive Toxicity Applicable to Large Scale Toxicological Programmes
Current Pharmaceutical Design Low Lymphocyte Count and Cardiovascular Diseases
Current Medicinal Chemistry DASH Dietary Pattern: A Treatment for Non-communicable Diseases
Current Hypertension Reviews Periodontitis, Endothelial Dysfunction and Atherosclerosis
Vascular Disease Prevention (Discontinued) The Role of Genes (and Environmental Stress) in Depression: An Update
Current Psychiatry Reviews Adiponectin and its Role in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets The Proteomic Approach in the Development of Prognostic Biomarkers in Atherothrombosis
Recent Patents on Cardiovascular Drug Discovery Some Important Dietary Polyphenolic Compounds: An Anti-inflammatory and Immunoregulatory Perspective
Mini-Reviews in Medicinal Chemistry Central Blood Pressure and Prediction of Cardiovascular Events
Current Hypertension Reviews